An expo, focused on demonstrating a new shape of pharmaceutical manufacturing in the post Covid-19 era was held from November 29 to December 1 at the India Expo Centre, Greater Noida, Delhi–NCR.
The 15th edition of CPHI & PMEC India, organised by Informa Markets in India, provided a unique opportunity to all the stakeholders to discuss the entire range of pharma machinery, analytical instruments, laboratory technologies and equipment, ancillaries, ingredients and more in a hybrid format.
The Trade Fair for pharma brought together over 50,000 visitors from across the globe, more than 1,500 exhibitors and representation from over 80 countries.
Addressing the opportunities in this sector, Yogesh Mudras, Managing Director, Informa Markets in India, said: “India’s pharmaceutical sector has done far more than prove itself in terms of manufacturing volumes and emerged as a life sciences leader within the post-pandemic order.”
“India’s pharmaceutical sector is a US $ 50 billion industry and is anticipated to grow to at least US $ 150 billion in less than a decade,” he said.
The government is also developing new strategies to strengthen the sector which has led to the creation of innovation hubs making India an ideal testing ground for innovations in digital health, he said.